INDORAMA
INDORAMA
Each stock's 10,000-path forecast, rendered as light.
INDORAMA (INDORAMA) Stock Analysis & Case Study
Is INDORAMA a good buy? The data-driven verdict.
INDORAMA (INDORAMA) trades at ₹46,on the numbers it mixed signals, a Downstox Snapshot Score of 53/100.
On the numbers, INDORAMA (INDORAMA) mixed signals, a Downstox Snapshot Score of 53/100, weighing inexpensive at 8.0× earnings, ROE of 34.5%, a 39% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027–2031.
Last updated . Data snapshot for research, not investment advice.
INDORAMA fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
Is INDORAMA overvalued? INDORAMA P/E vs its sector
INDORAMA's P/E of 8.0× sits below the sector peer median of 14.7×, so on earnings it screens cheaper than peers.
INDORAMA share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 2.0y of INDORAMA history (0%/yr drift, 50%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| INDORAMA 2027 | ₹21 | ₹40 | ₹77 | -12% |
| INDORAMA 2028 | ₹14 | ₹35 | ₹88 | -23% |
| INDORAMA 2029 | ₹10 | ₹31 | ₹96 | -33% |
| INDORAMA 2030 | ₹8 | ₹27 | ₹101 | -41% |
| INDORAMA 2031 | ₹6 | ₹25 | ₹104 | -47% |
Median (P50) is the central estimate; the P10–P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability INDORAMA goes up, or doubles?
The bull case for INDORAMA
- Trades at just 8.0× earnings, below the ~22× long-run Nifty average, so the valuation leaves room rather than pricing in perfection.
- High return on equity (34.5%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹96.
The bear case & risks
- A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing.
- The probability model is cautious 12 months out, only a 39% chance of finishing above today's price.
- High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹10.
INDORAMA volatility & expected range, how bumpy is the ride?
Over the last 2.0 years INDORAMA compounded at 0%/year with annualized volatility of 50%. That volatility implies a 1-year 80% range of ₹21–₹77, the honest backbone behind any single price target.
INDORAMA price forecast, the full 60-month probability fan
INDORAMA price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds INDORAMA hits common targets within the simulated horizon?
Full multi-horizon detail on the INDORAMA price target & forecast page.
INDORAMA Piotroski F-Score: 3/9, how financially strong is it?
The Piotroski F-Score grades financial strength on nine profitability, leverage and efficiency checks. INDORAMA scores 3/9,weak on the financial-strength checks.
INDORAMA MTF margin & leverage, Upstox, Zerodha, Groww, Dhan
Margin Trading Facility lets you buy INDORAMA with part of the capital. Lower margin % = higher leverage. Rates compared across brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| ZerodhaCHEAPEST | 50.0% | 2.0× |
Compare every broker on the INDORAMA MTF page.
INDORAMA vs peers,sector comparison
About INDORAMA: sector, index & market-cap context
INDORAMA (INDORAMA) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index group, with a market capitalisation of ₹1,217 Cr. See more Nifty 500 stocks.
How the INDORAMA Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of INDORAMA's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
INDORAMA analysis, FAQs
Is INDORAMA (INDORAMA) a good buy?
On the numbers, INDORAMA (INDORAMA) mixed signals, a Downstox Snapshot Score of 53/100, weighing inexpensive at 8.0× earnings, ROE of 34.5%, a 39% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is INDORAMA overvalued or undervalued?
INDORAMA trades at 8.0× earnings versus a peer median of 14.7×, so it screens cheaper than its sector peers.
What is the INDORAMA share price target for 2031?
INDORAMA's probability-weighted 2031 median target is ₹25, with an 80% range of ₹6–₹104 (10,000-path Monte-Carlo).
What is the probability INDORAMA doubles in 5 years?
The modelled probability of INDORAMA reaching ₹92 (2×) within 5 years is 12%.
What is the bull case for INDORAMA?
Trades at just 8.0× earnings, below the ~22× long-run Nifty average, so the valuation leaves room rather than pricing in perfection. High return on equity (34.5%), the business compounds shareholder capital efficiently, the hallmark of a quality franchise.
What are the risks in INDORAMA?
A low Piotroski F-Score of 3/9 flags weaker financial health this cycle, worth understanding why before committing. The probability model is cautious 12 months out, only a 39% chance of finishing above today's price. High historical volatility (50%/yr) means a wide, bumpy range of outcomes, size positions accordingly.